Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000284:Administration, Oral; D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D001692:Biological Transport; D001942:Breast Feeding; D005260:Female; D005333:Fetus / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008297:Male; D008431:Maternal-Fetal Exchange; D008895:Milk, Human / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D010920:Placenta / Q000032:analysis; D011247:Pregnancy; D051381:Rats
D010672:Phenytoin